The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and PTA balloon catheter segments, along with the evolving PV stent market. This market will grow moderately across all geographies covered through 2029, driven by increasing adoption of endovascular treatment modalities in the treatment of deep venous disease and introduction of new and innovative technologies. However, the market will be impacted in the short term by the COVID-19 pandemic.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the global market for deep venous disease treatment devices across a 10-year period.
The COVID-19 pandemic will cause a minimal decline in overall deep venous disease treatment procedure volumes and revenues in 2020.
How will the impact vary by country?
To what degree will the pandemic affect different deep venous disease treatment device segments?
Which procedures will be affected the most?
How soon will procedure volumes, sales, and revenues recover over the forecast period?
Dedicated venous stents are now available in many countries.
How will the introduction of dedicated venous stents impact the PV stent market?
How can companies leverage their presence in other segments of the deep venous disease treatment device market to boost the sales of venous stents?
Results from the ATTRACT clinical trial failed to show the superiority of endovascular treatment for thrombectomy and thrombolysis over anticoagulant therapy for treatment of VTE.
How will these negative results impact deep venous thrombectomy and thrombolysis procedures across the globe?
Will this data have an impact on the overall deep venous disease treatment device market?
Use of IVCFs for prophylactic indications is in question due to a lack of clearly favorable clinical data.
How will physician preference impact the dynamic IVCF market?
What strategies will companies adopt to address the safety concerns surrounding the use of IVCFs?
- Deep Venous Disease Treatment Devices - Market Insights - Global
Author(s): Pankhil Gandhi, PharmD
Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.